Andrés Cervantes
安德烈斯·塞万提斯
MD, PhD
Professor of Medical Oncology & ESMO Past President医学肿瘤学教授兼欧洲肿瘤学会前主席
👥Biography 个人简介
Andrés Cervantes is a world-leading GI oncologist at the University of Valencia and Past President of ESMO. Through CIBERONC and ESMO, he has built strong research bridges between Spain and Latin America, co-leading colorectal and gastric cancer trials that have enrolled heavily across Ibero-American sites and shaped global GI oncology guidelines.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Colorectal and Gastric Cancer Trials
Led or co-led multiple landmark phase III GI cancer trials including studies on bevacizumab, ramucirumab, and immunotherapy combinations, with significant enrollment from Ibero-American sites.
ESMO Global Guideline Development
As ESMO President, championed development of resource-stratified ESMO-MCBS guidelines applicable to Latin American and other LMIC contexts, improving local standard-setting.
Ibero-American Oncology Research Network
Co-founded collaborative research programs linking CIBERONC Spain with Latin American academic centers, facilitating joint clinical trials, data sharing, and training exchanges.
Representative Works 代表性著作
Ramucirumab plus FOLFIRI versus placebo plus FOLFIRI in patients with metastatic colorectal carcinoma (RAISE): a randomised, double-blind, multicentre, phase 3 study
The Lancet Oncology (2015)
Pivotal phase III trial establishing ramucirumab+FOLFIRI as second-line standard in mCRC; Cervantes was lead European PI with Latin American co-enrollment.
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology (2022)
Comprehensive ESMO guidelines for gastric cancer management, co-authored by Cervantes and adapted for use in Latin American ESMO MCBS frameworks.
Nivolumab plus ipilimumab versus FOLFOX for advanced oesophagogastric cancer (CheckMate 648): a randomised, open-label, phase 3 trial
The Lancet (2022)
Landmark immunotherapy trial in gastroesophageal cancer with Cervantes as a key investigator, redefining first-line treatment standards globally.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 安德烈斯·塞万提斯 的研究动态
Follow Andrés Cervantes's research updates
留下邮箱，当我们发布与 Andrés Cervantes（University of Valencia / INCLIVA Biomedical Research Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment